Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,084 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pediatric Chairs of Canada: academic pediatric workforce.
Scott B, Frewen T, O'Brodovich H; Paediatric Chairs of Canada. Scott B, et al. J Pediatr. 2004 Oct;145(4):425-6. doi: 10.1016/j.jpeds.2004.08.017. J Pediatr. 2004. PMID: 15480356 No abstract available.
Unpacking the NIH Toolbox Emotion Battery in Persons With Parkinson's disease.
Lopez FV, Schade R, Ratajska A, Kenney L, Rodriguez K, Ray A, Santos L, Scott BM, Trifilio E, Bowers D. Lopez FV, et al. Among authors: scott bm. Arch Clin Neuropsychol. 2022 Nov 29:acac088. doi: 10.1093/arclin/acac088. Online ahead of print. Arch Clin Neuropsychol. 2022. PMID: 36446750
Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the ASTCT Committee on Practice Guidelines.
DeFilipp Z, Ciurea SO, Cutler C, Robin M, Warlick ED, Nakamura R, Brunner AM, Dholaria B, Walker AR, Kroger N, Bejanyan N, Atallah E, Tamari R, Solh MM, Percival ME, de Lima M, Scott B, Oran B, Garcia-Manero G, Hamadani M, Carpenter P, DeZern AE. DeFilipp Z, et al. Among authors: scott b. Transplant Cell Ther. 2022 Nov 24:S2666-6367(22)01782-1. doi: 10.1016/j.jtct.2022.11.014. Online ahead of print. Transplant Cell Ther. 2022. PMID: 36436780
BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis.
Verstovsek S, Al-Ali HK, Mascarenhas J, Perkins A, Vannucchi AM, Mohan SR, Scott BL, Woszczyk D, Koschmieder S, García-Delgado R, László R, McGreivy JS, Rothbaum WP, Kiladjian JJ. Verstovsek S, et al. Among authors: scott bl. Future Oncol. 2022 Nov 23. doi: 10.2217/fon-2022-0901. Online ahead of print. Future Oncol. 2022. PMID: 36416118 Free article. Review.
2,084 results